Thyroxine replacement treatment and osteoporosis.
作者信息
Franklyn J A, Sheppard M C
机构信息
University of Birmingham, Queen Elizabeth Hospital.
出版信息
BMJ. 1990 Mar 17;300(6726):693-4. doi: 10.1136/bmj.300.6726.693.
Abstract
摘要
相似文献
1
Thyroxine replacement treatment and osteoporosis.甲状腺素替代治疗与骨质疏松症
BMJ. 1990 Mar 17;300(6726):693-4. doi: 10.1136/bmj.300.6726.693.
2
Thyroxine replacement treatment and osteoporosis.甲状腺素替代治疗与骨质疏松症
BMJ. 1990 Apr 21;300(6731):1074-5. doi: 10.1136/bmj.300.6731.1074-b.
3
Thyroxine, osteoporosis and fractures in the mentally handicapped.智障人群中的甲状腺素、骨质疏松症与骨折
West Engl Med J. 1990 Mar;105(1):25.
4
[Primary hypothyroidism: Considerations for a rational use of levothyroxine therapy].[原发性甲状腺功能减退症：左甲状腺素治疗合理应用的考量]
Med Clin (Barc). 2011 Feb 26;136(5):207-14. doi: 10.1016/j.medcli.2009.05.022. Epub 2009 Jul 30.
5
[Can substitution therapy with thyroxine cause osteoporosis?].[甲状腺素替代疗法会导致骨质疏松症吗？]
Tidsskr Nor Laegeforen. 1992 Jan 20;112(2):260-1.
6
Letter: Replacement treatment of hypothyroidism.信函：甲状腺功能减退症的替代治疗
N Engl J Med. 1974 Jul 11;291(2):100-3. doi: 10.1056/NEJM197407112910216.
7
Creatine treatment to relieve muscle pain caused by thyroxine replacement therapy.使用肌酸治疗以缓解甲状腺素替代疗法引起的肌肉疼痛。
Pain Med. 2012 Apr;13(4):616-9. doi: 10.1111/j.1526-4637.2012.01354.x. Epub 2012 Mar 28.
8
Thyroxine replacement therapy.甲状腺素替代疗法
Lancet. 1991 Jan 19;337(8734):171-2.
9
Which thyroxine?哪种甲状腺素？
Thyroid. 2005 Feb;15(2):124-6. doi: 10.1089/thy.2005.15.124.
10
Optimal LT4 dosage in primary hypothyroidism.
Iowa Med. 1994 Dec;84(12):535-7.
引用本文的文献
1
Exploring the mediating role of thyroid function in the effect of celiac disease on osteoporosis: A Mendelian randomization study.探索甲状腺功能在乳糜泻对骨质疏松症影响中的中介作用：一项孟德尔随机化研究。
Medicine (Baltimore). 2025 Jun 13;104(24):e42856. doi: 10.1097/MD.0000000000042856.
2
Are patients with primary hypothyroidism in India receiving appropriate thyroxine replacement? An observational study.印度原发性甲状腺功能减退症患者是否接受了适当的甲状腺素替代治疗？一项观察性研究。
Indian J Endocrinol Metab. 2014 Jan;18(1):83-8. doi: 10.4103/2230-8210.126582.
3
Adverse effects of thyroid hormones.甲状腺激素的不良反应。
Drugs Aging. 1997 Dec;11(6):460-9. doi: 10.2165/00002512-199711060-00005.
4
5
6
Thyroxine replacement treatment and osteoporosis.甲状腺素替代治疗与骨质疏松症
BMJ. 1990 Apr 21;300(6731):1074-5. doi: 10.1136/bmj.300.6731.1074-b.
7
Endocrinology.内分泌学
Postgrad Med J. 1991 Jan;67(783):23-32. doi: 10.1136/pgmj.67.783.23.
本文引用的文献
1
Grades of subclinical hypothyroidism in asymptomatic autoimmune thyroiditis revealed by the thyrotropin-releasing hormone test.促甲状腺激素释放激素试验揭示的无症状自身免疫性甲状腺炎中亚临床甲状腺功能减退的分级
J Clin Endocrinol Metab. 1980 Jul;51(1):163-6. doi: 10.1210/jcem-51-1-163.
2
Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for "tissue thyrotoxicosis".接受甲状腺素治疗的甲状腺功能减退患者中血清甲状腺素浓度升高与血清三碘甲状腺原氨酸值正常相关的意义：“组织甲状腺毒症”的实例
Br Med J (Clin Res Ed). 1984 Dec 15;289(6459):1645-7. doi: 10.1136/bmj.289.6459.1645.
3
Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine.接受甲状腺素维持替代治疗患者的总甲状腺激素和游离甲状腺激素浓度。
Br Med J (Clin Res Ed). 1984 Mar 3;288(6418):693-5. doi: 10.1136/bmj.288.6418.693.
4
Raised plasma glutathione S-transferase values in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: evidence for hepatic damage.甲状腺功能亢进症患者及接受甲状腺素替代治疗的甲状腺功能减退症患者血浆谷胱甘肽S-转移酶值升高：肝损伤的证据。
Br Med J (Clin Res Ed). 1985 Aug 17;291(6493):427-31. doi: 10.1136/bmj.291.6493.427.
5
Thyroxine replacement treatment: clinical judgment or biochemical control?甲状腺素替代治疗：临床判断还是生化指标控制？
Br Med J (Clin Res Ed). 1985 Jul 27;291(6490):233-4. doi: 10.1136/bmj.291.6490.233.
6
Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery.甲状腺功能减退与动脉粥样硬化性心脏病：发病机制、药物治疗及冠状动脉旁路移植术的作用
Endocr Rev. 1985 Summer;6(3):432-40. doi: 10.1210/edrv-6-3-432.
7
Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine.亚临床甲状腺功能亢进以及骨密度降低可能是长期使用左甲状腺素抑制垂体 - 甲状腺轴的结果。
Am J Med. 1987 Jun;82(6):1167-70. doi: 10.1016/0002-9343(87)90219-1.
8
Limitations of a sensitive assay for thyrotropin in managing patients with thyroid disease.甲状腺疾病患者管理中促甲状腺激素敏感检测法的局限性。
Clin Chem. 1988 May;34(5):991-2.
9
Thyroid hormone and the skeleton: a bone of contention.甲状腺激素与骨骼：一个有争议的问题。
JAMA. 1988 Jun 3;259(21):3175.
10
Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women.长期左旋甲状腺素治疗与绝经前女性髋部骨密度降低有关。
JAMA. 1988 Jun 3;259(21):3137-41.
Zotero 插件